{"id":192043,"date":"2026-08-10T09:44:39","date_gmt":"2026-08-10T04:14:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=192043"},"modified":"2026-08-10T09:44:39","modified_gmt":"2026-08-10T04:14:39","slug":"par-drugs-and-chemicals-ltd-share-price-rise-2026-08-10","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/par-drugs-and-chemicals-ltd-share-price-rise-2026-08-10\/","title":{"rendered":"Par Drugs And Chemicals Ltd. (PAR): Par Drugs And Chemicals Share Price Rises 8.73% Today"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/par\/par-drugs-and-chemicals-ltd-share-price-today\">Par Drugs And Chemicals Ltd.<\/a> traded at Rs 106.99, up 8.73% today, with a market capitalisation of Rs 121.08 crore, placing the micro-cap pharma stock among notable gainers.<\/p>\n<p style=\"margin-top:0!important;\">Par Drugs And Chemicals Share Price moved higher to Rs 106.99 on 10 August 2026, marking an 8.73% gain over the previous close of Rs 98.40 and taking the company\u2019s market capitalisation to Rs 121.08 crore. In today\u2019s Stock Market Today setup, that move is notable because the stock has cleared the qualifying price-rise bar applicable to its Micro Cap category, making it relevant in Par Drugs And Chemicals Stock News and among the market\u2019s early top gainer screens.<\/p>\n<p>The supplied data confirms the price event, the intraday range and the turnover, but it does not establish a company-specific catalyst behind the move. That distinction matters. For investors tracking Par Drugs And Chemicals Share Price Today, the fact pattern is clear: the stock opened at Rs 107.10, touched a high of Rs 108.00, slipped to a low of Rs 105.10 and still held a sharp gain at Rs 106.99 when this article was prepared at 10 August 2026 at 9:17:33 AM IST.<\/p>\n<p>Volume was modest in absolute terms at 4,214 shares on NSE, yet the percentage move is meaningful in a company of this size. That is why Par Drugs And Chemicals Share Price is showing up in Stocks in News and Market Movers lists. In this Univest analysis, the focus is not on speculation around why the stock is rising, but on what verified price, valuation, profitability, industry and peer data currently show, and what investors should monitor next.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Par_Drugs_And_Chemicals_Ltd_PAR_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Par Drugs And Chemicals Ltd. (PAR) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 106.99<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 98.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 8.59 (+8.73%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 107.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 108<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 105.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (NSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,214<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,214<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,214<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.05 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 121.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/table>\n<p>Par Drugs And Chemicals Ltd. (PAR) traded at Rs 106.99. versus the previous close of Rs 98.4, a rise of 8.73%. The stock opened at Rs 107.1, reached Rs 108, touched Rs 105.1. Reported volume was 4,214.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Par_Drugs_And_Chemicals_Ltd_PAR_Fundamental_Analysis\"><\/span><strong>Par Drugs And Chemicals Ltd. (PAR) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 121.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 11.78<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Par Drugs And Chemicals Ltd. was valued at a P\/E ratio of 8.35x, a P\/B ratio of 1.04x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 25.02% and ROCE of 28.68%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs 11.78, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<p>Par Drugs And Chemicals Share Price is attracting attention today, but the supplied financial ratios add a second layer of context: the stock is not expensive relative to its industry benchmark on the available multiples, while profitability metrics are stronger than broad industry medians and averages.<\/p>\n<p>Par Drugs And Chemicals Ltd. has a market capitalisation of Rs 121.08 crore, which places it firmly in the micro-cap bracket. Its price-to-earnings ratio is 8.35 and its price-to-book ratio is 1.04. Those are the two most important supplied valuation markers in this case, and both sit below the broader Pharmaceuticals &amp; Drugs industry benchmarks provided in the sector snapshot. An earnings multiple of 8.35 means investors are currently paying Rs 8.35 for every Rs 1 of trailing earnings represented by the company\u2019s EPS of Rs 11.78. That EPS is meaningful because it anchors the stock\u2019s low P\/E ratio in reported earnings rather than in a purely balance-sheet story.<\/p>\n<p>The book-value relationship also stands out. With a P\/B ratio of 1.04, the market is valuing the company only slightly above its accounting net worth. That matters in Par Drugs And Chemicals Fundamental Analysis because low P\/B levels can signal restrained market expectations relative to book equity, though they are not a judgment on quality by themselves. The supplied return ratios are stronger. ROE stands at 25.02% and ROCE at 28.68%, both of which indicate solid returns generated on shareholder equity and capital employed based on the reported data.<\/p>\n<p>Dividend yield is 0, which means the stock is not currently offering a cash-yield support layer through the supplied historical or current payout measure. For investors following Par Drugs And Chemicals Share Price Today, that places greater emphasis on earnings efficiency, capital returns and valuation rather than on income distribution. Overall, the financial snapshot shows a micro-cap pharma stock with low headline valuation multiples and strong return ratios. That does not explain today\u2019s move on its own, but it does give structure to why the stock may be drawing a closer look in Univest stock analysis coverage.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">80.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.21x to 3,417.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.93%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 121.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 142.44 crore<\/td>\n<\/tr>\n<\/table>\n<p>Par Drugs And Chemicals Ltd. (PAR) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Par Drugs And Chemicals Ltd. (PAR) has a P\/E ratio of 8.35x, which is below the benchmark median of 26.3x, a difference of -68.25%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Par Drugs And Chemicals Ltd. (PAR) has a ROE of 25.02%, which is above the benchmark median of 9.93%, a difference of +151.96%. Par Drugs And Chemicals Ltd. (PAR) has a ROCE of 28.68%, which is above the benchmark median of 12.96%, a difference of +121.3%.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>Par Drugs And Chemicals Share Price is moving within the Healthcare sector and the Pharmaceuticals &amp; Drugs industry, and the supplied benchmark data is useful because it places valuation and profitability in a much wider listed-company context. On those numbers, the company screens cheaper than the industry on P\/E and P\/B while posting stronger-than-benchmark return ratios.<\/p>\n<p>The sector snapshot is based on the same industry and covers 140 companies. Within that benchmark scope, the company\u2019s P\/E of 8.35 compares with a median P\/E of 26.30 and an average of 80.76, based on 104 companies with available P\/E data. The benchmark range runs from 3.21 to 3,417.80, which shows just how dispersed pharmaceutical valuations can be across listed names. Against that backdrop, Par Drugs And Chemicals Share Price appears to trade at a materially lower earnings multiple than the typical company in the supplied industry set.<\/p>\n<p>The pattern is similar on book value. The company\u2019s P\/B of 1.04 compares with an industry median of 1.83 and an average of 2.92 across 139 companies, with the benchmark ranging from -16.00 to 59.75. On profitability, however, the company\u2019s ROE of 25.02% is comfortably above the industry median of 9.93% and average of 7.45. ROCE of 28.68% also exceeds the industry median of 12.96% and average of 14.33 across 139 companies. That combination of lower valuation and stronger returns is a notable part of the current Par Drugs And Chemicals Stock Analysis.<\/p>\n<p>Size is the area where the company sits below the group\u2019s centre. Its market capitalisation of Rs 121.08 crore compares with an industry median of Rs 142.44 crore and an average of Rs 489.44 crore, while the broader market-cap range spans Rs 2.09 crore to Rs 3,032.97 crore. So, in sector terms, this is a smaller healthcare name with comparatively stronger profitability metrics and lower valuation multiples than the industry benchmark supplied to Univest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,032.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,799.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,707.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,631.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">63.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,531.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<\/table>\n<p>Par Drugs And Chemicals Ltd. (PAR) has a P\/E ratio of 8.35x compared with the displayed peer median of 31.12x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.02% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 28.68% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Par Drugs And Chemicals Ltd. (PAR) has a market capitalisation of Rs 121.08 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<p>Par Drugs And Chemicals Share Price looks distinct when set against the supplied listed peers in Pharmaceuticals &amp; Drugs. The main takeaway is straightforward: the company is much smaller in market capitalisation than the peer set, yet its reported profitability compares favourably with several bigger names while its valuation remains lower than many peers with available P\/E data.<\/p>\n<p>At Rs 121.08 crore in market capitalisation, Par Drugs And Chemicals Ltd. is far below the peer companies listed in the supplied snapshot, all of which are above Rs 2,057.85 crore. Dishman Carbogen Amcis Ltd. stands at Rs 3,032.97 crore with a P\/E of 31.12, P\/B of 0.45, ROE of -2.89% and ROCE of -0.26%. Hikal Ltd. has a market cap of Rs 2,799.54 crore, P\/B of 2.35, ROE of 15.22% and ROCE of 16.15%. Kwality Pharmaceuticals Ltd. is valued at Rs 2,707.20 crore, with a P\/E of 40.20, P\/B of 8.18, ROE of 28.21% and ROCE of 26.35%.<\/p>\n<p>Beta Drugs Ltd. carries a market cap of Rs 2,631.45 crore and trades at a P\/E of 63.43 with P\/B of 6.27, ROE of 18.65% and ROCE of 22.17%. Sai Parenteral&#8217;s Ltd. is at Rs 2,513.58 crore with a P\/E of 176.28, P\/B of 3.26, ROE of 13.90% and ROCE of 12.97%. NGL Fine-Chem Ltd. is at Rs 2,118.60 crore with P\/E of 44.02, P\/B of 6.43, ROE of 27.90% and ROCE of 33.91%. Venus Remedies Ltd. trades at Rs 2,068.61 crore with a P\/E of 17.81, P\/B of 3.01, ROE of 9.85% and ROCE of 7.89%, while Hester Biosciences Ltd. is at Rs 2,057.85 crore with a P\/E of 15.11, P\/B of 4.52, ROE of 16.17% and ROCE of 14.12%.<\/p>\n<p>Against this group, Par Drugs And Chemicals Share Price reflects a company with a lower P\/E of 8.35 than the peers where P\/E is available, and a lower P\/B of 1.04 than most of the supplied names except Dishman Carbogen Amcis. Its ROE of 25.02% is above several peers and close to the upper end of the listed comparison set, while ROCE of 28.68% also compares well. The trade-off is scale: investors are looking at a much smaller company than the rest of the peer basket.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Par_Drugs_And_Chemicals\"><\/span><strong>Why Investors Are Watching Par Drugs And Chemicals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Par Drugs And Chemicals Share Price is being watched because today\u2019s move combines a meaningful single-day gain with a valuation profile that looks restrained relative to the supplied industry benchmark. In a session where Top Gainers Today and Stocks Rising Today are drawing attention, the stock\u2019s micro-cap size makes percentage moves especially visible, while its profitability ratios add depth to the story.<\/p>\n<ul>\n<li><strong>Verified price action:<\/strong> the stock rose Rs 8.59, or 8.73%, from Rs 98.40 to Rs 106.99.<\/li>\n<li><strong>Intraday positioning:<\/strong> it opened at Rs 107.10, hit Rs 108.00 and held above the day low of Rs 105.10.<\/li>\n<li><strong>Trading activity:<\/strong> turnover was Rs 0.05 crore and total traded volume on NSE was 4,214 shares.<\/li>\n<li><strong>Fundamental context:<\/strong> P\/E at 8.35 and P\/B at 1.04 are below the supplied industry median and average figures.<\/li>\n<li><strong>Profitability:<\/strong> ROE of 25.02% and ROCE of 28.68% are above the same-industry benchmark medians.<\/li>\n<li><strong>Sector position:<\/strong> the company operates in Healthcare within Pharmaceuticals &amp; Drugs, a benchmark set covering 140 companies.<\/li>\n<\/ul>\n<p>What investors may monitor next is whether Par Drugs And Chemicals Share Price continues to hold gains around today\u2019s opening zone, and whether the market continues to value the company at a discount to peers and the wider industry despite stronger return ratios. For Univest readers, the stock is worth tracking because the current setup is defined by verified price action plus a clear valuation-versus-profitability contrast.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Par_Drugs_And_Chemicals\"><\/span><strong>About Par Drugs And Chemicals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Par Drugs And Chemicals Ltd. is classified in the Healthcare sector and operates within the Pharmaceuticals &amp; Drugs industry. That means the company sits inside one of the most closely watched pockets of the Indian Stock Market, where investors often compare earnings multiples, return ratios and scale across listed manufacturers and drug-focused businesses.<\/p>\n<p>Based on the supplied company context, the clearest verified way to understand the business is through its market positioning rather than through an unsupported operating narrative. Par Drugs And Chemicals Ltd. is a micro-cap listed company with a market capitalisation of Rs 121.08 crore, which puts it well below the larger listed pharmaceutical peers in the comparison set. Even so, the stock\u2019s financial profile stands out because its P\/E ratio of 8.35 and P\/B ratio of 1.04 are lower than many listed names in the same industry sample, while its ROE of 25.02% and ROCE of 28.68% are stronger than broad benchmark averages.<\/p>\n<p>For readers following Par Drugs And Chemicals Share Price Live and Par Drugs And Chemicals Latest News, that positioning matters. This is not one of the sector\u2019s largest listed names by market value, but it is part of an industry where relative valuation, earnings efficiency and capital returns can quickly bring smaller companies into focus when price action turns positive. That is why today\u2019s gain has lifted the stock into broader Univest market coverage.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Par_Drugs_And_Chemicals_Share_Price_on_Univest\"><\/span><strong>Track Par Drugs And Chemicals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/par\/par-drugs-and-chemicals-ltd-share-price-today\">Par Drugs And Chemicals Ltd. (PAR) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors who want to follow Par Drugs And Chemicals Share Price can track it on Univest for live share price updates, key ratio monitoring and broader market context. Univest coverage helps users watch Par Drugs And Chemicals Share Price Today alongside market capitalisation, P\/E ratio, P\/B ratio, ROE, ROCE, EPS, dividend yield and industry comparison data. Users can also follow 52-week levels when available, daily price action, turnover, volume trends and shareholding pattern updates when reported. For readers comparing Stocks in News and Market News across NSE and BSE screens, Univest offers a structured way to monitor Par Drugs And Chemicals Stock News without relying on unsupported narratives.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Par_Drugs_And_Chemicals_Share_Price_in_focus_today\"><\/span><strong>Why is Par Drugs And Chemicals Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Par Drugs And Chemicals Share Price is in focus because the stock rose 8.73% to Rs 106.99 from the previous close of Rs 98.40. That move cleared the qualifying price-rise bar for its Micro Cap category on NSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_latest_traded_price_of_Par_Drugs_And_Chemicals_Ltd\"><\/span><strong>What was the latest traded price of Par Drugs And Chemicals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest supplied traded price for Par Drugs And Chemicals Ltd. was Rs 106.99. At that level, the stock was up Rs 8.59 on the day, compared with its previous close of Rs 98.40.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Par_Drugs_And_Chemicals_Share_Price_move_during_the_session\"><\/span><strong>How did Par Drugs And Chemicals Share Price move during the session?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Par Drugs And Chemicals Share Price opened at Rs 107.10, touched an intraday high of Rs 108.00 and a low of Rs 105.10. It later traded at Rs 106.99, showing that most of the day\u2019s gain was retained.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Par_Drugs_And_Chemicals_Ltd\"><\/span><strong>What is the market capitalisation of Par Drugs And Chemicals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Par Drugs And Chemicals Ltd. had a market capitalisation of Rs 121.08 crore in the supplied data. That places the company in the Micro Cap category, which makes percentage moves like today\u2019s 8.73% gain especially noticeable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_valuation_ratios_suggest_for_Par_Drugs_And_Chemicals\"><\/span><strong>What do the valuation ratios suggest for Par Drugs And Chemicals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock\u2019s P\/E ratio is 8.35 and its P\/B ratio is 1.04. Both are below the Pharmaceuticals &amp; Drugs industry benchmark median values of 26.30 for P\/E and 1.83 for P\/B in the supplied snapshot.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Par_Drugs_And_Chemicals_based_on_supplied_ratios\"><\/span><strong>How profitable is Par Drugs And Chemicals based on supplied ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s ROE stands at 25.02% and ROCE at 28.68% based on the supplied data. Both figures are above the same-industry benchmark medians of 9.93% for ROE and 12.96% for ROCE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_EPS_and_dividend_yield_of_Par_Drugs_And_Chemicals_Ltd\"><\/span><strong>What is the EPS and dividend yield of Par Drugs And Chemicals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Par Drugs And Chemicals Ltd. reported an EPS of Rs 11.78 in the supplied data, while dividend yield was 0. This indicates the current financial profile is being viewed more through earnings and valuation than payout support.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_trading_activity_was_seen_in_the_stock_today\"><\/span><strong>How much trading activity was seen in the stock today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied trading activity showed current volume of 4,214 shares, with NSE volume and total volume also at 4,214. Turnover stood at Rs 0.05 crore, indicating a modest traded value despite the sharp percentage gain.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Par_Drugs_And_Chemicals_compare_with_larger_pharma_peers\"><\/span><strong>How does Par Drugs And Chemicals compare with larger pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Par Drugs And Chemicals is much smaller at Rs 121.08 crore market capitalisation than peers such as Hikal, Beta Drugs and Hester Biosciences, all above Rs 2,000 crore. Yet its P\/E of 8.35 is lower than many supplied peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_and_industry_does_Par_Drugs_And_Chemicals_belong_to\"><\/span><strong>Which sector and industry does Par Drugs And Chemicals belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Par Drugs And Chemicals Ltd. belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied sector benchmark covers 140 companies, giving useful context for comparing valuation, profitability and market-cap positioning.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Par Drugs And Chemicals Ltd. Share Price rises to Rs Rs 106.99. marking a 8.73% rise today. clearing the 8.1% threshold for Micro Cap stocks. Market cap stands<\/p>\n","protected":false},"author":29,"featured_media":192042,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-192043","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["192042"],"rank_math_title":["Par Drugs And Chemicals Share Price Up 8.73%: Stock Analysis"],"rank_math_description":["Par Drugs And Chemicals Share Price rose 8.73% to Rs 106.99. Read price action, valuation, profitability, sector benchmark and peer analysis."],"rank_math_focus_keyword":["Par Drugs And Chemicals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Par_Drugs_And_Chemicals_Ltd_PAR_Par_Drugs_And_Chemicals_Share_Price_Rises_873_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/192043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=192043"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/192043\/revisions"}],"predecessor-version":[{"id":192044,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/192043\/revisions\/192044"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/192042"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=192043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=192043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=192043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}